A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea

CompletedOBSERVATIONAL

Enrollment

3,623

Participants

Timeline

Start Date

April 19, 2014

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Alogliptin Benzoate

Alogliptin benzoate tablets

Trial Locations (22)

Andong

Anyang-si

Bucheon-si

Busan

Daegu

Daejeon

Gimhae

Gongju

Goyang-si

Gwangju

Gyeongju

Incheon

Jeonju

Namyangju

Osan

Seongnam

Seongnam-si

Seoul

Suncheon

Suwon

Ulsan

Wŏnju